Table 3.
Association of serum GP-88 levels with patient and tumor characteristics.
| Characteristic | Median (range) ng/ml | Mean GP88 ng/ml | P-value* |
|---|---|---|---|
| Age | |||
| <50 | 37.8 (9.8–105.8) | 40.2 | |
| ≥50 | 39.5 (6.4–158.4) | 43.8 | 0.19 |
| Race | |||
| Caucasian | 38.3 (9.8–100.0) | 40.7 | 0.27 |
| African American | 39.4 (6.4–158.4) | 43.8 | |
| ER | |||
| + | 38.0 (15.1–158.4) | 42.0 | 0.96 |
| – | 38.7 (6.4–105.8) | 42.2 | |
| PR | |||
| + | 37.9 (15.1–85.3) | 41.4 | 1.0 |
| – | 38.7 (6.4–105.8) | 41.4 | |
| HER2 | |||
| + | 37.4 (9.8–85.3) | 41.0 | 0.99 |
| – | 39.0 (6.4–105.8) | 40.9 | |
| Grade | |||
| 1 | 41.2 (15.1–158.4) | 45.6 | 0.45 |
| 2 | 39.0 (16.1–100.0) | 41.8 | |
| 3 | 37.9 (6.4–105.8) | 40.3 |
Notes:
*
P values are computed based on t tests for all comparisons except for comparison among grades, which is based on analysis of variance.